Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity

Papers of special note have been highlighted as: ▪ of interest

Bibliography

• 1  Shah JP, Singh B: Keynote comment: why the lack of progress for oral cancer?. Lancet Oncol.7(5),356–357 (2006).
  MedlineGoogle Scholar
• 2  Rodriguez T, Altieri A, Chatenoud L et al.: Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol.40(2),207–213 (2004).
  MedlineGoogle Scholar
• 3  Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC: Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J. Oral. Pathol. Med.24(10),450–453 (1995).
  Medline CASGoogle Scholar
• 4  Ha PK, Califano JA: The role of human papillomavirus in oral carcinogenesis. Crit. Rev. Oral Biol. Med.15(4),188–196 (2004).
  MedlineGoogle Scholar
• 5  Garavello W, Bertuccio P, Levi F et al.: The oral cancer epidemic in central and eastern Europe. Int. J. Cancer (2009) (Epub ahead of print).
  Google Scholar
• 6  de Camargo Cancela M, Voti L, Guerra-Yi M, Chapuis F, Mazuir M, Curado MP: Oral cavity cancer in developed and in developing countries: population-based incidence. Head Neck32(3),357–367 (2010).
  MedlineGoogle Scholar
• 7  Chien CY, Su CY, Chuang HC et al.: Comprehensive study on the prognostic role of osteopontin expression in oral squamous cell carcinoma. Oral Oncol.45(9),798–802 (2009).
  Medline CASGoogle Scholar
• 8  Schantz SP, Yu GP: Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer. Arch. Otolaryngol. Head Neck Surg.128(3),268–274 (2002).
  MedlineGoogle Scholar
• 9  Myers JN, Elkins T, Roberts D, Byers RM: Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol. Head Neck Surg.122(1),44–51 (2000).
  Medline CASGoogle Scholar
• 10  Ghoshal S, Mallick I, Panda N, Sharma SC: Carcinoma of the buccal mucosa: analysis of clinical presentation, outcome and prognostic factors. Oral Oncol.42(5),533–539 (2006).
  MedlineGoogle Scholar
• 11  Datema FR, Ferrier MB, van der Schroeff MP, Baatenburg de Jong RJ: Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients. Head Neck (2009) (Epub ahead of print).
  Google Scholar
• 12  Liao CT, Wang HM, Hsieh LL et al.: Higher distant failure in young age tongue cancer patients. Oral Oncol.42(7),718–725 (2006).
  MedlineGoogle Scholar
• 13  Vargas H, Pitman KT, Johnson JT, Galati LT: More aggressive behavior of squamous cell carcinoma of the anterior tongue in young women. Laryngoscope110(10 Pt 1),1623–1626 (2000).
  Medline CASGoogle Scholar
• 14  Woolgar JA, Rogers S, West CR, Errington RD, Brown JS, Vaughan ED: Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol.35(3),257–265 (1999).
  Medline CASGoogle Scholar
• 15  Liao CT, Ng SH, Chang JT et al.: T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol.43(6),570–579 (2007).
  MedlineGoogle Scholar
• 16  Huang SF, Kang CJ, Lin CY et al.: Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer112(5),1066–1075 (2008).
  MedlineGoogle Scholar
• 17  Pitman KT, Johnson JT, Myers EN: Effectiveness of selective neck dissection for management of the clinically negative neck. Arch. Otolaryngol. Head Neck Surg.123(9),917–922 (1997).
  Medline CASGoogle Scholar
• 18  Shah JP, Cendon RA, Farr HW, Strong EW: Carcinoma of the oral cavity. Factors affecting treatment failure at the primary site and neck. Am. J. Surg.132(4),504–507 (1976).
  Medline CASGoogle Scholar
• 19  Kalnins IK, Leonard AG, Sako K, Razack MS, Shedd DP: Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity. Am. J. Surg.134(4),450–454 (1977).
  Medline CASGoogle Scholar
• 20  Kokemueller H, Brachvogel P, Eckardt A, Hausamen JE: Neck dissection in oral cancer – clinical review and analysis of prognostic factors. Int. J. Oral Maxillofac. Surg.31(6),608–614 (2002).
  Medline CASGoogle Scholar
• 21  Shaw RJ, Lowe D, Woolgar JA et al.: Extracapsular spread in oral squamous cell carcinoma. Head Neck (2009) (Epub ahead of print).
  Google Scholar
• 22  Sano D, Myers JN: Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.26(3–4),645–662 (2007).
  Medline CASGoogle Scholar
• 23  Liao CT, Wang HM, Chang JT et al.: Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer110(7),1501–1508 (2007).
  MedlineGoogle Scholar
• 24  Kowalski LP, Bagietto R, Lara JR, Santos RL, Silva JF Jr, Magrin J: Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck22(3),207–214 (2000).
  Medline CASGoogle Scholar
• 25  Gil Z, Carlson DL, Boyle JO et al.: Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer115(24),5700–5710 (2009).
  MedlineGoogle Scholar
• 26  Shrime MG, Ma C, Gullane PJ et al.: Impact of nodal ratio on survival in squamous cell carcinoma of the oral cavity. Head Neck31(9),1129–1136 (2009).▪ Both nodal ratio and the phenomenon of extracapsular spread of lymph node are independent prognostic factors in disease-specific survival of oral cancer.
  MedlineGoogle Scholar
• 27  Shrime MG, Bachar G, Lea J et al.: Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck31(11),1482–1488 (2009).
  MedlineGoogle Scholar
• 28  Shaha AR, Spiro RH, Shah JP, Strong EW: Squamous carcinoma of the floor of the mouth. Am. J. Surg.148(4),455–459 (1984).
  Medline CASGoogle Scholar
• 29  Maddox WA: Hayes Martin lecture. Vicissitudes of head and neck cancer. Am. J. Surg.148(4),428–432 (1984).
  Medline CASGoogle Scholar
• 30  Asakage T, Yokose T, Mukai K et al.: Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue. Cancer82(8),1443–1448 (1998).
  Medline CASGoogle Scholar
• 31  Chuang HC, Su CY, Huang HY, Chien CY, Chen CM, Huang CC: High expression of CD105 as a prognostic predictor of early tongue cancer. Laryngoscope116(7),1175–1179 (2006).▪ Higher expression of either CD105 or VEGF in the tumor bed indicates a more aggressive potential for T1 and T2 tongue cancers, and the expression of CD105 is a useful predictive prognostic factor in early tongue cancer.
  Medline CASGoogle Scholar
• 32  Huang SH, Hwang D, Lockwood G, Goldstein DP, O’Sullivan B: Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer115(7),1489–1497 (2009).
  Medline CASGoogle Scholar
• 33  Po Wing Yuen A, Lam KY, Lam LK et al.: Prognostic factors of clinically stage I and II oral tongue carcinoma – a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez–Gimeno score, and pathologic features. Head Neck24(6),513–520 (2002).
  MedlineGoogle Scholar
• 34  Bier-Laning CM, Durazo-Arvizu R, Muzaffar K, Petruzzelli GJ: Primary tumor thickness as a risk factor for contralateral cervical metastases in T1/T2 oral tongue squamous cell carcinoma. Laryngoscope119(5),883–888 (2009).
  MedlineGoogle Scholar
• 35  Liao CT, Chang JT, Wang HM et al.: Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann. Surg. Oncol.15(3),915–922 (2008).
  MedlineGoogle Scholar
• 36  Woolgar JA, Scott J: Prediction of cervical lymph node metastasis in squamous cell carcinoma of the tongue/floor of mouth. Head Neck17(6),463–472 (1995).
  Medline CASGoogle Scholar
• 37  Odell EW, Jani P, Sherriff M et al.: The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer74(3),789–794 (1994).
  Medline CASGoogle Scholar
• 38  Okamoto M, Ozeki S, Watanabe T, Iida Y, Tashiro H: Cervical lymph node metastasis in carcinoma of the tongue. Correlation between clinical and histopathological findings and metastasis. J. Craniomaxillofac. Surg.16(1),31–34 (1988).
  Medline CASGoogle Scholar
• 39  Sawair FA, Irwin CR, Gordon DJ, Leonard AG, Stephenson M, Napier SS: Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J. Oral. Pathol. Med.32(1),1–9 (2003).
  MedlineGoogle Scholar
• 40  Yang TL, Ko JY, Chang YL: Involved margin of tongue cancer: the impact of tumor satellites on prognosis. Head Neck30(7),845–851 (2008).
  MedlineGoogle Scholar
• 41  Sugarbaker EV: Cancer metastasis: a product of tumor–host interactions. Curr. Probl. Cancer3(7),1–59 (1979).
  Medline CASGoogle Scholar
• 42  Close LG, Burns DK, Reisch J, Schaefer SD: Microvascular invasion in cancer of the oral cavity and oropharynx. Arch. Otolaryngol. Head Neck Surg.113(11),1191–1195 (1987).
  Medline CASGoogle Scholar
• 43  Fagan JJ, Collins B, Barnes L, D’Amico F, Myers EN, Johnson JT: Perineural invasion in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg.124(6),637–640 (1998).
  Medline CASGoogle Scholar
• 44  Rahima B, Shingaki S, Nagata M, Saito C: Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.97(4),423–431 (2004).
  MedlineGoogle Scholar
• 45  Goodman M, Liu L, Ward K et al.: Invasion characteristics of oral tongue cancer: frequency of reporting and effect on survival in a population-based study. Cancer115(17),4010–4020 (2009).
  MedlineGoogle Scholar
• 46  Chen YW, Yu EH, Wu TH, Lo WL, Li WY, Kao SY: Histopathological factors affecting nodal metastasis in tongue cancer: analysis of 94 patients in Taiwan. Int. J. Oral Maxillofac. Surg.37(10),912–916 (2008).
  Medline CASGoogle Scholar
• 47  D’Cruz AK, Siddachari RC, Walvekar RR et al.: Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: need for a randomized controlled trial. Head Neck31(5),618–624 (2009).
  MedlineGoogle Scholar
• 48  Pandey M, Bindu R, Soumithran CS: Results of primary versus salvage surgery in carcinoma of the buccal mucosa. Eur. J. Surg. Oncol.35(4),362–367 (2009).
  Medline CASGoogle Scholar
• 49  Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB: Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck26(11),984–994 (2004).
  MedlineGoogle Scholar
• 50  Liao CT, Chang JT, Wang HM et al.: Does adjuvant radiation therapy improve outcomes in pT1–3N0 oral cavity cancer with tumor-free margins and perineural invasion?. Int. J. Radiat. Oncol. Biol. Phys.71(2),371–376 (2008).
  MedlineGoogle Scholar
• 51  Bernier J: Incorporation of molecularly targeted agents in the primary treatment of squamous cell carcinomas of the head and neck. Hematol. Oncol. Clin. North Am.22(6),1193–1208, ix (2008).
  MedlineGoogle Scholar
• 52  Lilling G, Elena N, Sidi Y, Bakhanashvili M: p53-associated 3´>5´ exonuclease activity in nuclear and cytoplasmic compartments of cells. Oncogene22(2),233–245 (2003).
  MedlineGoogle Scholar
• 53  Hamakawa H, Nakashiro K, Sumida T et al.: Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. Head Neck30(6),800–809 (2008).
  MedlineGoogle Scholar
• 54  Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell61(5),759–767 (1990).
  Medline CASGoogle Scholar
• 55  Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G, Gorgoulis VG: Advances in the biology of oral cancer. Oral Oncol.43(6),523–534 (2007).
  Medline CASGoogle Scholar
• 56  Hanahan D, Weinberg RA: The hallmarks of cancer. Cell100(1),57–70 (2000).
  Medline CASGoogle Scholar
• 57  Brinkman BM, Wong DT: Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr. Opin. Oncol.18(3),228–233 (2006).▪ Discusses ongoing research to identify biomarkers for oral cancer.
  Medline CASGoogle Scholar
• 58  Nagpal JK, Das BR: Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol.39(3),213–221 (2003).
  Medline CASGoogle Scholar
• 59  Sidransky D: Molecular genetics of head and neck cancer. Curr. Opin. Oncol.7(3),229–233 (1995).
  Medline CASGoogle Scholar
• 60  Califano J, van der Riet P, Westra W et al.: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res.56(11),2488–2492 (1996).
  Medline CASGoogle Scholar
• 61  Kupferman ME, Myers JN: Molecular biology of oral cavity squamous cell carcinoma. Otolaryngol. Clin. North Am.39(2),229–247 (2006).▪ Describes the current knowledge of molecular processes that underlie tumorigenesis in squamous cell carcinoma of the oral cavity.
  MedlineGoogle Scholar
• 62  Kresty LA, Mallery SR, Knobloch TJ et al.: Alterations of p16(^INK4a) and p14(^ARF) in patients with severe oral epithelial dysplasia. Cancer Res.62(18),5295–5300 (2002).
  Medline CASGoogle Scholar
• 63  Choi S, Myers JN: Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J. Dent. Res.87(1),14–32 (2008).▪ Focuses on the molecular mechanisms of oral carcinogenesis and the use of biologic therapy to specifically target molecules altered in squamous cell carcinoma of the oral cavity.
  Medline CASGoogle Scholar
• 64  Williams HK. Molecular pathogenesis of oral squamous carcinoma. Mol. Pathol.53(4),165–172 (2000).
  Medline CASGoogle Scholar
• 65  Grandis JR, Tweardy DJ: Elevated levels of transforming growth factor a and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res.53(15),3579–3584 (1993).
  Medline CASGoogle Scholar
• 66  Huang SF, Chuang WY, Chen IH, Liao CT, Wang HM, Hsieh LL: EGFR protein overexpression and mutation in areca quid-associated oral cavity squamous cell carcinoma in Taiwan. Head Neck31(8),1068–1077 (2009).
  MedlineGoogle Scholar
• 67  Hynes NE, Lane HA: ErbB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer5(5),341–354 (2005).
  Medline CASGoogle Scholar
• 68  Shiraki M, Odajima T, Ikeda T et al.: Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. Mod. Pathol.18(11),1482–1489 (2005).
  Medline CASGoogle Scholar
• 69  Chen IH, Chang JT, Liao CT, Wang HM, Hsieh LL, Cheng AJ: Prognostic significance of EGFR and HER-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br. J. Cancer89(4),681–686 (2003).
  Medline CASGoogle Scholar
• 70  Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P, Eccles SA: Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev.24(1),47–69 (2005).
  Medline CASGoogle Scholar
• 71  Grandis JR, Drenning SD, Zeng Q et al.: Constitutive activation of STAT3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl Acad. Sci. USA97(8),4227–4232 (2000).
  Medline CASGoogle Scholar
• 72  Reuter CW, Morgan MA, Eckardt A: Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck. Br. J. Cancer96(3),408–416 (2007).
  Medline CASGoogle Scholar
• 73  Rittling SR, Chambers AF: Role of osteopontin in tumour progression. Br. J. Cancer90(10),1877–1881 (2004).
  Medline CASGoogle Scholar
• 74  Rangaswami H, Bulbule A, Kundu GC: Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol.16(2),79–87 (2006).
  Medline CASGoogle Scholar
• 75  Weber GF. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim. Biophys. Acta1552(2),61–85 (2001).
  Medline CASGoogle Scholar
• 76  Haqq C, Nosrati M, Sudilovsky D et al.: The gene expression signatures of melanoma progression. Proc. Natl Acad. Sci. USA102(17),6092–6097 (2005).
  Medline CASGoogle Scholar
• 77  Wai PY, Kuo PC: The role of osteopontin in tumor metastasis. J. Surg. Res.121(2),228–241 (2004).
  Medline CASGoogle Scholar
• 78  Todd R, Donoff RB, Wong DT: The molecular biology of oral carcinogenesis: toward a tumor progression model. J. Oral Maxillofac. Surg.55(6),613–623; discussion 623–615 (1997).
  Medline CASGoogle Scholar
• 79  Milasin J, Pujic N, Dedovic N, Nikolic Z, Petrovic V, Dimitrijevic B: High incidence of H-RAS oncogene mutations in squamous cell carcinoma of lip vermilion. J. Oral. Pathol. Med.23(7),298–301 (1994).
  Medline CASGoogle Scholar
• 80  Kuo MY, Jeng JH, Chiang CP, Hahn LJ: Mutations of KI-RAS oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. J. Oral. Pathol. Med.23(2),70–74 (1994).
  Medline CASGoogle Scholar
• 81  Darnell JE Jr: Transcription factors as targets for cancer therapy. Nat. Rev. Cancer2(10),740–749 (2002).
  Medline CASGoogle Scholar
• 82  Darnell JE Jr, Kerr IM, Stark GR: Jak–STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science264(5164),1415–1421 (1994).
  Medline CASGoogle Scholar
• 83  Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene19(21),2468–2473 (2000).
  Medline CASGoogle Scholar
• 84  Siavash H, Nikitakis NG, Sauk JJ: Signal transducers and activators of transcription: insights into the molecular basis of oral cancer. Crit. Rev. Oral Biol. Med.15(5),298–307 (2004).
  Medline CASGoogle Scholar
• 85  Masuda M, Suzui M, Yasumatu R et al.: Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res.62(12),3351–3355 (2002).
  Medline CASGoogle Scholar
• 86  Klosek SK, Nakashiro K, Hara S, Li C, Shintani S, Hamakawa H: Constitutive activation of STAT3 correlates with increased expression of the c-Met/HGF receptor in oral squamous cell carcinoma. Oncol. Rep.12(2),293–296 (2004).
  Medline CASGoogle Scholar
• 87  Lothaire P, de Azambuja E, Dequanter D et al.: Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck28(3),256–269 (2006).
  MedlineGoogle Scholar
• 88  Miyamoto R, Uzawa N, Nagaoka S, Hirata Y, Amagasa T: Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas. Oral Oncol.39(6),610–618 (2003).
  Medline CASGoogle Scholar
• 89  Rousseau A, Lim MS, Lin Z, Jordan RC: Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias. Oral Oncol.37(3),268–275 (2001).
  Medline CASGoogle Scholar
• 90  Yu Z, Weinberger PM, Haffty BG et al.: Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin. Cancer Res.11(3),1160–1166 (2005).
  Medline CASGoogle Scholar
• 91  Chen HM, Yen-Ping Kuo M, Lin KH, Lin CY, Chiang CP: Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan. Oral Oncol.39(5),476–482 (2003).
  MedlineGoogle Scholar
• 92  Chen CH, Su CY, Chien CY et al.: Overexpression of β2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion. Br. J. Cancer99(9),1453–1461 (2008).▪ First report that β2-microglobulin participated in oral cancer cell migration and invasion.
  Medline CASGoogle Scholar
• 93  Chen CH, Chien CY, Huang CC et al.: Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity. Oncogene28(30),2723–2737 (2009).▪ First report that FLJ10540 could regulate the FOXM1/MMP-2 pathway for modulating the oral cancer cell migration and invasion.
  Medline CASGoogle Scholar
• 94  Reiter R, Gais P, Jutting U et al.: Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin. Cancer Res.12(17),5136–5141 (2006).
  Medline CASGoogle Scholar
• 95  Chen YJ, Chang JT, Lee L et al.: DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene26(3),467–476 (2007).
  Medline CASGoogle Scholar
• 96  Kudo Y, Kitajima S, Ogawa I, Kitagawa M, Miyauchi M, Takata T: Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation. Mol. Cancer Ther.4(3),471–476 (2005).
  Medline CASGoogle Scholar
• 97  Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ: Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study. Cancer Lett.225(2),297–304 (2005).
  Medline CASGoogle Scholar
• 98  Brener S, Gonzalez-Moles MA, Tostes D et al.: A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma. Anticancer Res.29(6),2323–2329 (2009).
  MedlineGoogle Scholar
• 99  Lo WY, Tsai MH, Tsai Y et al.: Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin. Chim. Acta376(1–2),101–107 (2007).
  Medline CASGoogle Scholar
• 100  Chang JT, Wang HM, Chang KW et al.: Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1. Int. J. Cancer114(6),942–949 (2005).
  Medline CASGoogle Scholar
• 101  Schliephake H. Prognostic relevance of molecular markers of oral cancer – a review. Int. J. Oral Maxillofac. Surg.32(3),233–245 (2003).
  Medline CASGoogle Scholar
• 102  Chien CY, Su CY, Chuang HC et al.: Angiopoietin-1 and -2 expression in recurrent squamous cell carcinoma of the oral cavity. J. Surg. Oncol.97(3),273–277 (2008).
  MedlineGoogle Scholar
• 103  Poznic M: Retinoblastoma protein: a central processing unit. J. Biosci.34(2),305–312 (2009).
  Medline CASGoogle Scholar
• 104  Sartor M, Steingrimsdottir H, Elamin F et al.: Role of p16/MTS1, cyclin D1 and Rb in primary oral cancer and oral cancer cell lines. Br. J. Cancer80(1–2),79–86 (1999).
  Medline CASGoogle Scholar
• 105  Scambia G, Lovergine S, Masciullo V: Rb family members as predictive and prognostic factors in human cancer. Oncogene25(38),5302–5308 (2006).
  Medline CASGoogle Scholar
• 106  Massano J, Regateiro FS, Januario G, Ferreira A: Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.102(1),67–76 (2006).
  MedlineGoogle Scholar
• 107  Baral R, Patnaik S, Das BR: Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India. Eur. J. Oral Sci.106(5),907–913 (1998).
  Medline CASGoogle Scholar
• 108  Lyons AJ, Jones J: Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma. Int. J. Oral Maxillofac. Surg.36(8),671–679 (2007).
  Medline CASGoogle Scholar
• 109  Choi CS, Choi G, Jung KY, Choi JO, Chae YS: Low expression of p27(Kip1) in advanced mucoepidermoid carcinomas of head and neck. Head Neck23(4),292–297 (2001).
  Medline CASGoogle Scholar
• 110  Kapranos N, Stathopoulos GP, Manolopoulos L et al.: p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Anticancer Res.21(1B),521–528 (2001).
  Medline CASGoogle Scholar
• 111  Mineta H, Miura K, Suzuki I et al.: Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer85(5),1011–1017 (1999).
  Medline CASGoogle Scholar
• 112  Fillies T, Woltering M, Brandt B et al.: Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas. Oncol. Rep.17(2),355–359 (2007).
  Medline CASGoogle Scholar
• 113  Ohta S, Uemura H, Matsui Y et al.: Alterations of p16 and p14^ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.107(1),81–91 (2009).
  MedlineGoogle Scholar
• 114  Buajeeb W, Poomsawat S, Punyasingh J, Sanguansin S: Expression of p16 in oral cancer and premalignant lesions. J. Oral. Pathol. Med.38(1),104–108 (2009).
  MedlineGoogle Scholar
• 115  Vairaktaris E, Yapijakis C, Psyrri A et al.: Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis. Anticancer Res.27(2),979–984 (2007).
  Medline CASGoogle Scholar
• 116  Oliveira DT, Sherriff M, Odell EW: Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas. J. Oral. Pathol. Med.27(7),303–307 (1998).
  Medline CASGoogle Scholar
• 117  Howell GM, Grandis JR: Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck27(8),710–717 (2005).
  MedlineGoogle Scholar
• 118  Van Waes C, Carey TE: Overexpression of the A9 antigen/a 6 b 4 integrin in head and neck cancer. Otolaryngol. Clin. North Am.25(5),1117–1139 (1992).
  Medline CASGoogle Scholar
• 119  Thomas GJ, Speight PM: Cell adhesion molecules and oral cancer. Crit. Rev. Oral Biol. Med.12(6),479–498 (2001).
  Medline CASGoogle Scholar
• 120  Thomas GJ, Nystrom ML, Marshall JF: αvβ6 integrin in wound healing and cancer of the oral cavity. J. Oral. Pathol. Med.35(1),1–10 (2006).
  Medline CASGoogle Scholar
• 121  Steeg PS: Metastasis suppressors alter the signal transduction of cancer cells. Nat. Rev. Cancer3(1),55–63 (2003).
  Medline CASGoogle Scholar
• 122  Jezierska A, Motyl T: Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med. Sci. Monit.15(2),RA32–RA40 (2009).
  Medline CASGoogle Scholar
• 123  Munshi HG, Wu YI, Ariztia EV, Stack MS: Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells. J. Biol. Chem.277(44),41480–41488 (2002).
  Medline CASGoogle Scholar
• 124  Chuang HC, Su CY, Huang HY et al.: Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma. Mod. Pathol.21(12),1444–1450 (2008).
  Medline CASGoogle Scholar
• 125  Werner JA, Rathcke IO, Mandic R: The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin. Exp. Metastasis19(4),275–282 (2002).
  Medline CASGoogle Scholar
• 126  Hong SD, Hong SP, Lee JI, Lim CY: Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol.36(2),207–213 (2000).
  Medline CASGoogle Scholar
• 127  Gao ZB, Duan YQ, Zhang L, Chen DW, Ding PT: Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma. Int. J. Mol. Med.16(4),599–603 (2005).
  Medline CASGoogle Scholar
• 128  Patel BP, Shah SV, Shukla SN, Shah PM, Patel PS: Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck29(6),564–572 (2007).
  MedlineGoogle Scholar
• 129  Mertens PR, Harendza S, Pollock AS, Lovett DH: Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J. Biol. Chem.272(36),22905–22912 (1997).
  Medline CASGoogle Scholar
• 130  Qin H, Sun Y, Benveniste EN: The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem.274(41),29130–29137 (1999).
  Medline CASGoogle Scholar
• 131  Bian J, Sun Y: Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell. Biol.17(11),6330–6338 (1997).
  Medline CASGoogle Scholar
• 132  Xie TX, Wei D, Liu M et al.: STAT3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene23(20),3550–3560 (2004).
  Medline CASGoogle Scholar
• 133  Fox SB, Gasparini G, Harris AL: Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol.2(5),278–289 (2001).
  Medline CASGoogle Scholar
• 134  Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG: Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br. J. Cancer96(7),1092–1100 (2007).
  Medline CASGoogle Scholar
• 135  Siriwardena BS, Kudo Y, Ogawa I, Udagama MN, Tilakaratne WM, Takata T: VEGF-C is associated with lymphatic status and invasion in oral cancer. J. Clin. Pathol.61(1),103–108 (2008).
  Medline CASGoogle Scholar
• 136  Zhang B, Pan X, Cobb GP, Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev. Biol.302(1),1–12 (2007).
  Medline CASGoogle Scholar
• 137  Liu X, Chen Z, Yu J, Xia J, Zhou X: MicroRNA profiling and head and neck cancer. Comp. Funct. Genomics837514 (2009).
  MedlineGoogle Scholar
• 138  Esquela-Kerscher A, Slack FJ: Oncomirs – microRNAs with a role in cancer. Nat. Rev. Cancer6(4),259–269 (2006).
  Medline CASGoogle Scholar
• 139  Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat. Rev. Cancer6(11),857–866 (2006).
  Medline CASGoogle Scholar
• 140  Shinawi M, Cheung SW: The array CGH and its clinical applications. Drug Discov. Today13(17–18),760–770 (2008).
  Medline CASGoogle Scholar
• 141  Mitelman F, Johansson B, Mertens F: The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer7(4),233–245 (2007).
  Medline CASGoogle Scholar
• 142  Sparano A, Quesnelle KM, Kumar MS et al.: Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope116(5),735–741 (2006).
  Medline CASGoogle Scholar
• 143  Kallioniemi A: CGH microarrays and cancer. Curr. Opin. Biotechnol.19(1),36–40 (2008).
  Medline CASGoogle Scholar
• 144  Ries J, Mollaoglu N, Toyoshima T et al.: A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma. Dis. Markers27(2),75–84 (2009).
  Medline CASGoogle Scholar
• 145  Nagler RM: Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol.45(12),1006–1010 (2009).
  Medline CASGoogle Scholar